RACHEL RIEDESEL: Open Payments
NPI 1396269221 · CLINTON, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$626 in 33 payments from 11 companies in 2025. Trend: 2023 $617 · 2024 $1,275 · 2025 $626
Food & beverage: $626
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $176 |
| PFIZER INC. | 6 | $116 |
| ABBVIE INC. | 3 | $67 |
| Novo Nordisk Inc | 3 | $52 |
| Insulet Corporation | 1 | $45 |
| Lilly USA, LLC | 2 | $41 |
| Dexcom, Inc. | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Exact Sciences Corporation | 1 | $17 |
Products named: VRAYLAR, EVENITY, ELIQUIS, Ozempic, KRYSTEXXA, OMNIPOD, OTEZLA, MOUNJARO.
Industry payments across IA — which companies pay providers there.
